Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

Iclusig (ponatinib) is a kinase inhibitor indicated for the: Treatment of adult patients with chronic phase, accelerated phase Chronic Myeloid Leukaemia (CML) who resistance or intolerance to tyrosine kinase inhibitor (dasatinib or nilotinib); Treatment of adult patients with T3151 positive CML (chronic phase, accelerated phase).
Limitation of use: Iclusig is not indicated and is not recommended for the treatment of patients with newly diagnosed chronic phase CML.

Iclusig Indications/Uses

ponatinib

Manufacturer:

Otsuka